Anthony P. Deasey,Patrick Frankham,Wolfgang Renz,Thomas Lang
申请号：
US13269491
公开号：
US20120089118A1
申请日:
2011.10.07
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A system for the administration of a bisphosphonate to a subject comprises a bisphosphonate formulation and a microinjection device. In an embodiment, the bisphosphonate formulation includes ibandronate sodium. In some cases, the bisphosphonate formulation includes an excipient. The bisphosphonate formulation may be delivered to the subject subcutaneously, transdermally or intradermally.
